Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 25.66% vs 9.54% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 12.11% vs 14.60% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 17.95% vs 18.80% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 17.39% vs 78.45% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Alembic Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 16.35% vs -1.52% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 25.66% vs 9.54% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -14.62% vs 52.44% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 12.11% vs 14.60% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 45.60% vs -22.34% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 17.95% vs 18.80% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 22.38% vs -3.22% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 17.39% vs 78.45% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






